Skip to main content
SKIN
NASDAQ Industrial Applications And Services

SkinHealth Q3: Net Loss Narrows to $0.9M, But $250M 2028 Notes Need Refinancing

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Household Product Stocks · Consumer
Sentiment info
Neutral
Importance info
7
Price
$10.35
Mkt Cap
$67.348M
52W Low
$9.68
52W High
$34.8
52W Position info
6.9% above low
Off High info
70% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

SKIN is trading near its 52-week low of $9.68 (6.9% above the low).

Summary

SkinHealth's Q3 net loss shrank to $0.9M from $11.0M on a 68.2% gross margin, but cash dropped to $112.4M after retiring the 2026 notes, and management says the $250M of 2028 notes will need refinancing.


Key Events · Earnings and Guidance · SKIN

  • Q3 Net Loss Narrows Sharply

    Net sales fell 2.1% to $69.2M, but gross margin rose to 68.2% from 64.6% and operating income swung to $5.0M from a $6.2M loss, cutting the net loss to $0.9M from $11.0M.

  • Cash Falls After 2026 Notes Retired

    Cash, cash equivalents and restricted cash dropped to $112.4M from $232.7M at December 31, 2025, after the company repaid the remaining $103.2M of 2026 Notes on September 30, 2026.

  • $250M 2028 Notes Need Refinancing

    The $250.0M of 7.95% convertible notes due November 15, 2028 exceed the $112.4M cash balance; management says satisfaction at maturity will require refinancing, restructuring or other additional capital, with no assurance of acceptable terms.

  • Securities Settlement Mostly Insured

    An $18.0M cash settlement payment is due into escrow by November 5, 2026, of which only $3.0M comes from company funds and $15.0M from insurers; final court approval hearing is December 9, 2026.


Analysis · SKIN · Industrial Applications And Services

The quarter itself marks a genuine turnaround on the cost line: gross margin rose to 68.2% from 64.6% and operating income swung to $5.0M from a $6.2M loss, cutting the net loss to $0.9M from $11.0M. The balance sheet is the concern. Cash fell to $112.4M from $232.7M at year-end, largely because the company retired the remaining $103.2M of 2026 Notes on September 30. That leaves $250.0M of 7.95% notes due November 15, 2028, and management states plainly that satisfying them will require refinancing, restructuring or other additional capital. With $112.4M of cash against that maturity, the refinancing is the real story behind the improved P&L. Separately, the $18.0M securities settlement is mostly insurer-funded — only $3.0M comes from company funds — with a final approval hearing set for December 9, 2026.

How filings like this one have moved

In the 30 days to Nov 6, 2026, 35.2% of the 2653 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, SKIN was trading at $10.35 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $67.3M. The 52-week trading range was $9.68 to $34.80. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SKIN - Latest Insights

SKIN
Nov 05, 2026, 4:13 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $10.35
Real-time Price: $10.35 info
Change: $0 (0%) info
Market Cap: $67.348M info
SKIN
Nov 05, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $10.35
Real-time Price: $10.35 info
Change: $0 (0%) info
Market Cap: $67.348M info
SKIN
Oct 06, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.586
Real-time Price: $10.35 info
Change: Reverse Stock Split info
Market Cap: $67.348M info
SKIN
Aug 12, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $0.6468
Real-time Price: $10.35 info
Change: Reverse Stock Split info
Market Cap: $67.348M info
SKIN
Aug 06, 2026, 5:17 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.693
Real-time Price: $10.35 info
Change: Reverse Stock Split info
Market Cap: $67.348M info